Skip to main content
. 2017 Oct 17;55(7):5741–5756. doi: 10.1007/s12035-017-0784-z

Fig. 6.

Fig. 6

Lipidomic analysis of lipid raft fractions. a, b Quantitation of 34:1 sphingomyelin and its corresponding ceramide species. There is no significant difference between vehicle- and GW4869 nSMase inhibitor-treated groups. cf Quantitation of longer chain 36:1 and 38:1 sphingomyelins and their corresponding ceramides. Sphingomyelins, but not ceramides, were significantly reduced by inhibitor treatment. Asterisks indicate significant differences compared to controls *p < 0.05